Sellas Life Sciences Group

(NASDAQ) SLS

Current Price$9.06

Market Cap$1.59B

Since IPO (2018)-97%

5 Year-36%

1 Year+454%

1 Month+10%

Sellas Life Sciences Group Financials at a Glance

Market Cap

$1.59B

Revenue (TTM)

$0.00

Net Income (TTM)

-$29.46M

EPS (TTM)

-$0.23

P/E Ratio

-37.35

Dividend

$0.00

Beta (Volatility)

1.29 (Average)

Dividend

$0.00

Beta (Volatility)

1.29 (Average)

Price

$9.06

Volume

7,186,993.535

Open

$8.50

Price

$9.06

Volume

7,186,993.535

Open

$8.50

Previous Close

$9.07

Daily Range

$8.46 - $9.25

52-Week Range

$1.39 - $9.51

Estimated Earnings Date

May 7, 2026

Dividend

$0.00

Beta (Volatility)

1.29 (Average)

Price

$9.06

Volume

7,186,993.535

Open

$8.50

Previous Close

$9.07

Daily Range

$8.46 - $9.25

52-Week Range

$1.39 - $9.51

Estimated Earnings Date

May 7, 2026

SLS News

No articles available.

SLS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sellas Life Sciences Group

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Angelos M. Stergiou, MD

Website

www.sellaslifesciences.com

Headquarters

New York, NY 10036, US

SLS Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-47.12%

Return on Capital

-39.34%

Return on Assets

-25.80%

Earnings Yield

-2.68%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.59B

Shares Outstanding

186.03M

Volume

7.19M

Avg. Volume

7.54M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$31.46M

EBITDA

-$22.37M

Operating Cash Flow

-$28.17M

Capital Expenditure

$0.00

Free Cash Flow

-$28.17M

Cash & ST Invst.

$107.20M

Total Debt

$871.00K

Sellas Life Sciences Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.59B

N/A

Market Cap/Employee

$122.07M

N/A

Employees

N/A

Net Income

-$8.41M

-44.6%

EBITDA

-$8.41M

-44.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$107.20M

+277.5%

Total Debt

$871.00K

+0.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$309.00K

+0.0%

Short Term Debt

$562.00K

+0.2%

Return on Assets

-25.80%

N/A

Return on Invested Capital

-29.21%

N/A

Free Cash Flow

-$8.85M

+2.5%

Operating Cash Flow

-$8.85M

+2.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GNFTGenfit S.A.

GNFTGenfit S.A.$8.95+4.07%

CCCCC4 Therapeutics, Inc.

CCCCC4 Therapeutics, Inc.$4.22+2.43%

OABIOmniAb, Inc.

OABIOmniAb, Inc.$2.33+0.43%

IVVDInvivyd, Inc.

IVVDInvivyd, Inc.$0.93+2.21%

PRLDPrelude Therapeutics Incorporated

PRLDPrelude Therapeutics Incorporated$4.38+1.39%

CDXSCodexis, Inc.

CDXSCodexis, Inc.$2.39+0.84%

TARAProtara Therapeutics, Inc.

TARAProtara Therapeutics, Inc.$4.00-2.68%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$17.29+0.01%

PFEPfizer

PFEPfizer$24.72-0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.44-0.10%

TAT&T

TAT&T$22.81+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.56+0.10%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.82-0.12%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.60-0.01%

Questions About SLS

What is the current price of Sellas Life Sciences Group?

Sellas Life Sciences Group is trading at $9.07 per share.

What is the 52-week range for Sellas Life Sciences Group?

Over the past 52 weeks, Sellas Life Sciences Group has traded between $1.39 and $9.51.

How much debt does Sellas Life Sciences Group have?

As of the most recent reporting period, Sellas Life Sciences Group reported total debt of $871.00K.

How much cash does Sellas Life Sciences Group have on hand?

Sellas Life Sciences Group reported $107.20M in cash and cash equivalents in its most recent financial results.

What is Sellas Life Sciences Group’s dividend yield?

Sellas Life Sciences Group does not currently have a dividend yield.

Sellas Life Sciences Group

Sellas Life Sciences Group Financials at a Glance

SLS News

SLS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sellas Life Sciences Group

SLS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sellas Life Sciences Group Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SLS

What is the current price of Sellas Life Sciences Group?

What is the 52-week range for Sellas Life Sciences Group?

How much debt does Sellas Life Sciences Group have?

How much cash does Sellas Life Sciences Group have on hand?

What is Sellas Life Sciences Group’s dividend yield?

Premium Investing Services